Sjogren-Larsson Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Sjogren-Larsson Syndrome

What is the definition of Sjogren-Larsson Syndrome?

Sjögren-Larsson syndrome is a condition that affects the skin and eyes as well as the brain and spinal cord (central nervous system).

What are the causes of Sjogren-Larsson Syndrome?

Variants (also called mutations) in the ALDH3A2 gene cause Sjögren-Larsson syndrome. The ALDH3A2 gene provides instructions for making an enzyme that is part of a multistep process called fatty acid oxidation in which fats are broken down and converted into energy. Specifically, the ALDH3A2 enzyme breaks down molecules called fatty aldehydes into fatty acids.

How prevalent is Sjogren-Larsson Syndrome?

Sjögren-Larsson syndrome affects approximately 1 in 100,000 individuals in Sweden, where the disease was first identified. Although this disease is found all over the world, the prevalence of Sjögren-Larsson syndrome in other countries is unknown.

Is Sjogren-Larsson Syndrome an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Sjogren-Larsson Syndrome Local Doctors?
Elite in Sjogren-Larsson Syndrome
Medical Genetics
Elite in Sjogren-Larsson Syndrome
Medical Genetics

Munroe Meyer Institute

6902 Pine Street, 
Omaha, NE 
Experience:
49+ years
Languages Spoken:
English

William Rizzo is a Medical Genetics provider practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 49 years. Dr. Rizzo is rated as an Elite provider by MediFind in the treatment of Sjogren-Larsson Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Sjogren-Larsson Syndrome, Zellweger Syndrome, Pompe Disease, and Danon Disease.

Advanced in Sjogren-Larsson Syndrome
Family Medicine
Advanced in Sjogren-Larsson Syndrome
Family Medicine

OSF Medical Group - Primary Care

210 Saint Joseph Drive, 
Bloomington, IL 
Languages Spoken:
English

Justin Holschbach is a primary care provider, practicing in Family Medicine in Bloomington, Illinois. Dr. Holschbach is rated as an Advanced provider by MediFind in the treatment of Sjogren-Larsson Syndrome. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Low Sodium Level, Peptic Ulcer, Necrosis, and Colorectal Cancer. Dr. Holschbach is board certified in American Board Of Family Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Sjogren-Larsson Syndrome
Endocrinology
Distinguished in Sjogren-Larsson Syndrome
Endocrinology

Tufts Medical Center

800 Washington St, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Ronald Lechan is an Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Lechan is rated as a Distinguished provider by MediFind in the treatment of Sjogren-Larsson Syndrome. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Prolactinoma, Langer Mesomelic Dysplasia, and Seckel Syndrome.

What are the latest Sjogren-Larsson Syndrome Clinical Trials?
The Myelin Disorders Biorepository Project and Global Leukodystrophy Initiative Clinical Trials Network

Summary: The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: December 18, 2025
Published By: National Institutes of Health